1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Canada Pharmaceuticals and Healthcare Report Q4 2016

Canada Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 93 pages

Includes 3 FREE quarterly updates


BMI View:
Canada has a number of domestic pharmaceutical firms and is a major market for foreignbased companies. Prospects for Canada's pharmaceutical market are relatively positive compared with many other developed countries. The government is not facing extreme fiscal pressures and the private sector makes a sizeable and complementary contribution to healthcare expenditure.
Headline Expenditure Projections


- Pharmaceuticals: CAD25.07bn (USD19.61bn) in 2015 to CAD25.83bn (USD19.87bn) in 2016; +3.0% in local currency terms and +1.3% in US dollar terms. We have revised our forecast upwards from the previous quarter on account of the improving economic and political environment.

- Healthcare: CAD209.92bn (USD164.17bn) in 2015 to CAD214.72bn (USD165.17bn) in 2016; +2.3% in local currency terms and +0.6% in US dollar terms. The forecast is unchanged from the previous quarter.

Table Of Contents

Canada Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Canada 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Canada 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Canada 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Canada 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Canada 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Canada 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Canada 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts (Canada 2014-2020) 30
Industry Risk Reward Index 31
Americas Risk/Reward Index 31
Canada Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Intellectual Property Issues 44
Pricing Regime 46
Reimbursement Regime 48
Market Overview 51
Healthcare Sector 51
Table: Healthcare Resources (Canada 2010-2015) 55
Table: Healthcare Personnel (Canada 2010-2015) 55
Table: Healthcare Activity (Canada 2010-2015) 56
Research and Development 56
Clinical Trials 59
Epidemiology 60
Competitive Landscape 63
Research-Based Industry 63
Table: Multinational Market Activity 66
Pharmaceutical Retail Sector 67
Company Profile 68
Apotex 68
GlaxoSmithKline 71
Merck 73
Novartis 75
Valeant 77
Demographic Forecast 82
Demographic Outlook 82
Table: Population Headline Indicators (Canada 1990-2025) 83
Table: Key Population Ratios (Canada 1990-2025) 83
Table: Urban/Rural Population and Life Expectancy (Canada 1990-2025) 84
Table: Population By Age Group (Canada 1990-2025) 84
Table: Population By Age Group % (Canada 1990-2025) 85
Glossary 87
Methodology 89
Pharmaceutical Expenditure Forecast Model 89
Healthcare Expenditure Forecast Model 89
Notes On Methodology 90
Risk/Reward Index Methodology 91
Index Overview 92
Table: Pharmaceutical Risk/Reward Index Indicators 92
Indicator Weightings 93

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.